» Articles » PMID: 33925465

Conformational and Immunogenicity Studies of the Serogroup 6 O-Antigen: The Effect of O-Acetylation

Overview
Date 2021 Apr 30
PMID 33925465
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The pathogenic bacterium is a leading cause of diarrheal disease and mortality, disproportionately affecting young children in low-income countries. The increasing prevalence of antibiotic resistance in necessitates an effective vaccine, for which the bacterial lipopolysaccharide O-antigen is the primary target. serotype 6 has been proposed as a multivalent vaccine component to ensure broad protection against . We have previously explored the conformations of O-antigens from serogroups Y, 2, 3, and 5 that share a common saccharide backbone (serotype Y). Here we consider serogroup 6, which is of particular interest because of an altered backbone repeat unit with non-stoichiometric O-acetylation, the antigenic and immunogenic importance of which have yet to be established. Our simulations show significant conformational changes in serogroup 6 relative to the serotype Y backbone. We further find that O-acetylation has little effect on conformation and hence may not be essential for the antigenicity of serotype 6. This is corroborated by an in vivo study in mice, using Generalized Modules for Membrane Antigens (GMMA) as O-antigen delivery systems, that shows that O-acetylation does not have an impact on the immune response elicited by the serotype 6 O-antigen.

Citing Articles

Salmonella Typhimurium derived OMV nanoparticle displaying mixed heterologous O-antigens confers immunogenicity and protection against STEC infections in mice.

Bian X, Chen Y, Zhang W, Liu X, Lei M, Yuan H Microb Cell Fact. 2025; 24(1):8.

PMID: 39773741 PMC: 11705740. DOI: 10.1186/s12934-024-02640-6.


Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens.

Lei E, Azmat A, Henry K, Hussack G Appl Microbiol Biotechnol. 2024; 108(1):232.

PMID: 38396192 PMC: 10891261. DOI: 10.1007/s00253-024-13033-5.


Development of the 2a, 3a, 6, and artificial Invaplex (Invaplex) vaccines.

Ross Turbyfill K, Clarkson K, Oaks E, Zurawski D, Vortherms A, Kaminski R mSphere. 2023; 8(4):e0007323.

PMID: 37389412 PMC: 10449495. DOI: 10.1128/msphere.00073-23.


Conformational comparisons of Pasteurella multocida types B and E and structurally related capsular polysaccharides.

Richardson N, Ravenscroft N, Kuttel M Glycobiology. 2023; 33(9):745-754.

PMID: 37334939 PMC: 10627249. DOI: 10.1093/glycob/cwad049.


Semisynthetic Glycoconjugate Vaccine Candidates against O25B Induce Functional IgG Antibodies in Mice.

Naini A, Bartetzko M, Sanapala S, Broecker F, Wirtz V, Lisboa M JACS Au. 2022; 2(9):2135-2151.

PMID: 36186572 PMC: 9516715. DOI: 10.1021/jacsau.2c00401.


References
1.
. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1151-1210. PMC: 5605883. DOI: 10.1016/S0140-6736(17)32152-9. View

2.
Hlozek J, Owen S, Ravenscroft N, Kuttel M . Molecular Modeling of the Serogroup 3 and 5 O-Antigens and Conformational Relationships for a Vaccine Containing Serotypes 2a and 3a. Vaccines (Basel). 2020; 8(4). PMC: 7712985. DOI: 10.3390/vaccines8040643. View

3.
Hlozek J, Kuttel M, Ravenscroft N . Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation. Carbohydr Res. 2018; 465:44-51. DOI: 10.1016/j.carres.2018.06.007. View

4.
Phillips J, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E . Scalable molecular dynamics with NAMD. J Comput Chem. 2005; 26(16):1781-802. PMC: 2486339. DOI: 10.1002/jcc.20289. View

5.
Hlozek J, Ravenscroft N, Kuttel M . Effects of Glucosylation and O-Acetylation on the Conformation of Serogroup 2 O-Antigen Vaccine Targets. J Phys Chem B. 2020; 124(14):2806-2814. DOI: 10.1021/acs.jpcb.0c01595. View